Acumen Pharmaceuticals Inc. (ABOS) NASDAQ
$3.14 (0.02) (-0.63%)
Market Cap: $189.85M
As of 04/19/24 03:59 PM EDT. Market closed.
Acumen Pharmaceuticals Inc. (ABOS)
NASDAQ
$3.14
(0.02) (-0.63%)
Market Cap: $189.85M
As of 04/19/24 03:59 PM EDT. Market closed.
acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (a?o) in synaptic dysfunction and neurodegeneration. these early insights have fostered ... read more
acumen is forging a new path towards safe and effective treatments for alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers. our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (a?o) in synaptic dysfunction and neurodegeneration. these early insights have fostered decades of research on the biology of a?o at acumen and throughout the field. we are now on the on cusp of realizing the therapeutic potential of a?o targeted drugs. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| OConnell Daniel Joseph | President and CEO | Jan 19, 2024 | Sale | $3.47 | 15,200 | 52,753 | 502,485 | Jan 19, 2024, 07:07 PM |
| Meisner Derek M | Chief Legal Officer & Corp Sec | Jan 19, 2024 | Sale | $3.48 | 8,933 | 31,048 | 108,867 | Jan 19, 2024, 07:06 PM |
| Zuga Matt | CFO & Chief Business Officer | Jan 18, 2024 | Sale | $3.70 | 4,242 | 15,717 | 211,445 | Jan 19, 2024, 07:05 PM |
| Siemers Eric | Chief Medical Officer | Jan 18, 2024 | Sale | $3.71 | 3,124 | 11,604 | 117,576 | Jan 19, 2024, 07:05 PM |
| Barton Russell | Chief Operating Officer | Jan 18, 2024 | Sale | $3.73 | 2,833 | 10,555 | 96,867 | Jan 19, 2024, 07:04 PM |
| Ives Jeffrey L. | Director | Aug 17, 2023 | Option Exercise | $0.75 | 41,949 | 31,519 | 39,149 | Aug 18, 2023, 06:31 PM |
| Ives Jeffrey L. | Director | Aug 17, 2023 | Sale | $6.49 | 41,949 | 272,334 | 0 | Aug 18, 2023, 06:31 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 21, 2023 | Buy | $7.75 | 5,161,290 | 39,999,998 | 13,043,179 | Jul 25, 2023, 04:30 PM |
| Zuga Matt | CFO and Chief Business Officer | Dec 29, 2022 | Option Exercise | $1.19 | 50,000 | 59,500 | 76,187 | Jan 03, 2023, 05:23 PM |
| OConnell Daniel Joseph | President and CEO | Nov 30, 2021 | Option Exercise | $4.47 | 1,118 | 4,997 | 2,685 | Dec 02, 2021, 04:41 PM |
| Manning Paul B | 10% Owner | Jul 06, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 3,352,693 | Jul 08, 2021, 06:35 PM |
| Stalfort John A III | Director | Jul 06, 2021 | Buy | $16.00 | 35,000 | 560,000 | 172,324 | Jul 08, 2021, 06:17 PM |
| OConnell Daniel Joseph | President and CEO | Jul 06, 2021 | Option Exercise | $16.00 | 10 | 160 | 1,567 | Jul 08, 2021, 06:16 PM |
| OConnell Daniel Joseph | President and CEO | Jul 06, 2021 | Option Exercise | $4.47 | 35 | 156 | 1,577 | Jul 08, 2021, 06:16 PM |
| Hardie Robert D. | 10% Owner | Jul 06, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 3,352,693 | Jul 08, 2021, 06:15 PM |
| Hardie Robert D. | 10% Owner | Jul 06, 2021 | Buy | $16.00 | 750,000 | 12,000,000 | 3,951,156 | Jul 08, 2021, 06:14 PM |
| Fountain Nathan B | Director | Jul 06, 2021 | Buy | $16.00 | 6,250 | 100,000 | 6,250 | Jul 08, 2021, 06:13 PM |
| Sands Capital Ventures Discovery Fund III, L.P. | 10% Owner | Jul 06, 2021 | Buy | $14.88 | 450,000 | 6,696,000 | 3,417,075 | Jul 08, 2021, 05:21 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 06, 2021 | Buy | $16.00 | 1,875,000 | 30,000,000 | 7,881,889 | Jul 08, 2021, 04:32 PM |
| Owner | Relationship | Date | Value($) |
| OConnell Daniel Joseph | President and CEO | 01/19/2024 | 52,753 |
| Meisner Derek M | Chief Legal Officer & Corp Sec | 01/19/2024 | 31,048 |
| Zuga Matt | CFO & Chief Business Officer | 01/18/2024 | 15,717 |
| Siemers Eric | Chief Medical Officer | 01/18/2024 | 11,604 |
| Barton Russell | Chief Operating Officer | 01/18/2024 | 10,555 |
| Ives Jeffrey L. | Director | 08/17/2023 | 31,519 |
| Ives Jeffrey L. | Director | 08/17/2023 | 272,334 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/21/2023 | 39,999,998 |
| Zuga Matt | CFO and Chief Business Officer | 12/29/2022 | 59,500 |
| OConnell Daniel Joseph | President and CEO | 11/30/2021 | 4,997 |
| Manning Paul B | 10% Owner | 07/06/2021 | 5,000,000 |
| Stalfort John A III | Director | 07/06/2021 | 560,000 |
| OConnell Daniel Joseph | President and CEO | 07/06/2021 | 160 |
| OConnell Daniel Joseph | President and CEO | 07/06/2021 | 156 |
| Hardie Robert D. | 10% Owner | 07/06/2021 | 5,000,000 |
| Hardie Robert D. | 10% Owner | 07/06/2021 | 12,000,000 |
| Fountain Nathan B | Director | 07/06/2021 | 100,000 |
| Sands Capital Ventures Discovery Fund III, L.P. | 10% Owner | 07/06/2021 | 6,696,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/06/2021 | 30,000,000 |
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 14,932,063 | 0.9% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 264,603 | 0.00011% | No change | Other |
| BLACKROCK INC. | 248,095 | 0.00002% | -57.48% | Other |
| D. E. SHAW & CO., INC. | 138,029 | 0.00046% | New | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 20,578 | 0.00015% | New | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View